236 related articles for article (PubMed ID: 18037114)
1. Targeting B lymphocytes as therapy for ANCA-associated vasculitis.
Golbin JM; Specks U
Rheum Dis Clin North Am; 2007 Nov; 33(4):741-54, v. PubMed ID: 18037114
[TBL] [Abstract][Full Text] [Related]
2. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.
Keogh KA; Wylam ME; Stone JH; Specks U
Arthritis Rheum; 2005 Jan; 52(1):262-8. PubMed ID: 15641078
[TBL] [Abstract][Full Text] [Related]
3. Rituximab and antineutrophil cytoplasmic antibody-associated vasculitis: granulomatous disease more resistant than vasculitis disease?
Wong CF
J Clin Rheumatol; 2008 Apr; 14(2):61-4. PubMed ID: 18391671
[No Abstract] [Full Text] [Related]
4. TNF-alpha bioactivity-inhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations.
Huugen D; Tervaert JW; Heeringa P
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1100-7. PubMed ID: 17699331
[TBL] [Abstract][Full Text] [Related]
5. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
6. ANCA-associated renal vasculitis--epidemiology, diagnostics and treatment.
Ríhová Z; Jancová E; Merta M; Tesar V
Prague Med Rep; 2004; 105(3):237-60. PubMed ID: 15782551
[TBL] [Abstract][Full Text] [Related]
7. Immunopathology of ANCA-associated vasculitis.
Csernok E; Müller A; Gross WL
Intern Med; 1999 Oct; 38(10):759-65. PubMed ID: 10526937
[TBL] [Abstract][Full Text] [Related]
8. Necrotizing vasculitis--a 2009 update.
Sharaf PH; Yazici Y
Bull NYU Hosp Jt Dis; 2009; 67(3):303-5. PubMed ID: 19852754
[TBL] [Abstract][Full Text] [Related]
9. [Vasculitis attacking the kidneys].
Grönhagen-Riska C; Teppo AM
Duodecim; 1995; 111(15):1442-51. PubMed ID: 9244700
[No Abstract] [Full Text] [Related]
10. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.
Smith KG; Jones RB; Burns SM; Jayne DR
Arthritis Rheum; 2006 Sep; 54(9):2970-82. PubMed ID: 16947528
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.
Kallenberg CG
Curr Opin Rheumatol; 2007 Jan; 19(1):17-24. PubMed ID: 17143091
[TBL] [Abstract][Full Text] [Related]
12. Plasma exchange in the treatment of Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis.
Casian A; Jayne D
Curr Opin Rheumatol; 2011 Jan; 23(1):12-7. PubMed ID: 21124082
[TBL] [Abstract][Full Text] [Related]
13. [ANCA-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). 3. Therapeutic procedure].
Reinhold-Keller E; Tatsis E; Gross WL
Z Rheumatol; 1995; 54(5):303-9. PubMed ID: 8578886
[TBL] [Abstract][Full Text] [Related]
14. Primary systemic vasculitis.
Day C; Savage C
Minerva Med; 2001 Oct; 92(5):349-63. PubMed ID: 11675579
[TBL] [Abstract][Full Text] [Related]
15. Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients.
Lovric S; Erdbruegger U; Kümpers P; Woywodt A; Koenecke C; Wedemeyer H; Haller H; Haubitz M
Nephrol Dial Transplant; 2009 Jan; 24(1):179-85. PubMed ID: 18685144
[TBL] [Abstract][Full Text] [Related]
16. B cell targeted therapies in autoimmune diseases.
Isenberg DA
J Rheumatol Suppl; 2006 May; 77():24-8. PubMed ID: 16652442
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
18. Rituximab in ANCA-associated vasculitis: fad or fact?
Fervenza FC
Nephron Clin Pract; 2011; 118(2):c182-8; discussion c188. PubMed ID: 21160229
[TBL] [Abstract][Full Text] [Related]
19. [ANCA: vasculitis research on the upswing].
Michel BA
Z Rheumatol; 1995; 54(5):277-8. PubMed ID: 8578883
[No Abstract] [Full Text] [Related]
20. Rituximab in refractory antineutrophil cytoplasmic antibody-associated vasculitis: what is the current evidence?
Wong CF
Nephrol Dial Transplant; 2007 Jan; 22(1):32-6. PubMed ID: 17056639
[No Abstract] [Full Text] [Related]
[Next] [New Search]
